|
GTX01501
|
GeneTex International Corporation
|
WGA Lectin (Biotin)
|
|
ELISA, IHC, WB
|
|
|
GTX01504
|
GeneTex International Corporation
|
ConA Lectin (Biotin)
|
|
ELISA, IHC, WB
|
|
|
GTX16376
|
GeneTex International Corporation
|
Trident Blue Prestained Protein Ladder
|
|
WB
|
|
|
GTX29909
|
GeneTex International Corporation
|
TissueBond slide adhesive
|
|
IHC-Fr, IHC-P
|
|
|
GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
|
GTX30924
|
GeneTex International Corporation
|
Immuno In Situ Mount
|
|
IHC
|
|
|
GTX30949
|
GeneTex International Corporation
|
Streptavidin (HRP)
|
|
ELISA, IHC, WB
|
|
|
GTX30954
|
GeneTex International Corporation
|
Streptavidin (AP)
|
|
ELISA, IHC, WB
|
|
|
GTX400006
|
GeneTex International Corporation
|
Trident plus Western HRP Substrate
|
|
WB
|
|
|
GTX425858
|
GeneTex International Corporation
|
EasyBlocker
|
|
WB
|
|
|
GTX425858-S
|
GeneTex International Corporation
|
EasyBlocker
|
|
WB
|
|
|
HY-101559-50ug
|
MedChemexpress LLC
|
10-Nitrooleic acid [CAS 875685-46-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101559S-100ug
|
MedChemexpress LLC
|
10-Nitrooleate-d17 (nitrate) [CAS 2749984-40-3]
|
|
|
|
|
HY-10294-10mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10294-25mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10294-5mg
|
MedChemexpress LLC
|
Relacatib [CAS 362505-84-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-103243-10mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-100mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-25mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-5mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-103243-50mg
|
MedChemexpress LLC
|
TCPOBOP [CAS 76150-91-9]
|
|
Cancer-programmed cell death
|
|
|
HY-10569-10mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-100mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-5mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10569-50mg
|
MedChemexpress LLC
|
Ponesimod [CAS 854107-55-4]
|
|
COVID-19-immunoregulation
|
|
